MDPHP (3',4'-Methylenedioxy-α-pyrrolidinohexiophenone) is a
stimulant of the
cathinone class originally developed in the 1960s, which has been reported as a novel
designer drug
A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests. D ...
. In the UK its slang name is ''monkey dust''. It is closely related to the potent stimulant
MDPV
Methylenedioxypyrovalerone (MDPV) is a stimulant of the cathinone class that acts as a norepinephrine–dopamine reuptake inhibitor (NDRI). It was first developed in the 1960s by a team at Boehringer Ingelheim. Its activity at the dopamine tra ...
though with slightly milder effects, and has been used as an alternative in some countries following the banning of MDPV.
Legal Status
MDPHP is specifically listed as a controlled substance in Japan and Hungary,
and is controlled under
analogue provisions in a number of other jurisdictions.
See also
*
α-Pyrrolidinohexiophenone (α-PHP)
*
3',4'-Methylenedioxy-α-pyrrolidinopropiophenone
3',4'-Methylenedioxy-α-pyrrolidinopropiophenone (MDPPP) is a stimulant designer drug. It was sold in Germany in the late 1990s and early 2000s as an ingredient in imitation ecstasy (MDMA) pills. It shares a similar chemical structure with α-P ...
(MDPPP)
*
N-Ethylhexedrone
''N''-Ethylhexedrone (also known as α-ethylaminocaprophenone, ''N''-ethylnorhexedrone, hexen, and NEH) is a stimulant of the cathinone class that acts as a norepinephrine–dopamine reuptake inhibitor (NDRI) with IC50 values of 0.0978 and 0.0 ...
*
N-Ethylhexylone
''N''-Ethylhexylone is a recreational designer drug from the substituted cathinone family, with stimulant effects. It was first identified in Poland in August 2019. It is illegal in Taiwan since July 2020, where it had been sold mixed with plan ...
References
Designer drugs
Pyrrolidinophenones
Benzodioxoles
Butyl compounds
{{nervous-system-drug-stub